Cargando…

Cancer progression by breast tumors with Pit-1-overexpression is blocked by inhibition of metalloproteinase (MMP)-13

INTRODUCTION: The POU class 1 homeobox 1 transcription factor (POU1F1, also known as Pit-1) is expressed in the mammary gland and its overexpression induces profound phenotypic changes in proteins involved in cell proliferation, apoptosis, and invasion. Patients with breast cancer and elevated expre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sendon-Lago, Juan, Seoane, Samuel, Eiro, Noemi, Bermudez, Maria A, Macia, Manuel, Garcia-Caballero, Tomas, Vizoso, Francisco J, Perez-Fernandez, Roman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4305241/ https://www.ncbi.nlm.nih.gov/pubmed/25527274 http://dx.doi.org/10.1186/s13058-014-0505-8

Ejemplares similares

Erratum to: Cancer progression by breast tumors with Pit-1-overexpression is blocked by inhibition of metalloproteinase (MMP)-13
por: Sendon-Lago, Juan, et al.
Publicado: (2017)

Pit-1 inhibits BRCA1 and sensitizes human breast tumors to cisplatin and vitamin D treatment
por: Seoane, Samuel, et al.
Publicado: (2015)

Potential therapeutic effect of the secretome from human uterine cervical stem cells against both cancer and stromal cells compared with adipose tissue stem cells
por: Eiró, Noemí, et al.
Publicado: (2014)

POU1F1 transcription factor induces metabolic reprogramming and breast cancer progression via LDHA regulation
por: Martínez-Ordoñez, Anxo, et al.
Publicado: (2021)

Cytokines related to MMP-11 expression by inflammatory cells and breast cancer metastasis
por: Eiró, Noemi, et al.
Publicado: (2013)

The Pit-1/Pou1f1 transcription factor regulates and correlates with prolactin expression in human breast cell lines and tumors
por: Ben-Batalla, I, et al.
Publicado: (2010)

MMP1 and MMP11 Expression in Peripheral Blood Mononuclear Cells upon Their Interaction with Breast Cancer Cells and Fibroblasts
por: Eiro, Noemi, et al.
Publicado: (2020)

Tailored Hydrogels as Delivery Platforms for Conditioned Medium from Mesenchymal Stem Cells in a Model of Acute Colitis in Mice
por: Sendon-Lago, Juan, et al.
Publicado: (2021)

Joint Tumor Bud–MMP/TIMP Count at the Invasive Front Improves the Prognostic Evaluation of Invasive Breast Carcinoma
por: González, Luis O., et al.
Publicado: (2021)

Mesenchymal Stem/Stromal Cells and Their Derivates in Acute Diseases: Emergency in the Post-COVID-19 Times
por: Vizoso, Francisco J., et al.
Publicado: (2021)

Quantification of matrix metalloproteinases MMP-8 and MMP-9 in gingival overgrowth
por: Orozco-Páez, Jennifer, et al.
Publicado: (2021)

Mesenchymal Stem Cell Secretome: Toward Cell-Free Therapeutic Strategies in Regenerative Medicine
por: Vizoso, Francisco J., et al.
Publicado: (2017)

The Role of Matrix Metalloproteinases (MMP-8, MMP-9, MMP-13) in Periodontal and Peri-Implant Pathological Processes
por: Luchian, Ionut, et al.
Publicado: (2022)

Matrix Metalloproteinases and Bladder Cancer: What is New?
por: Rodriguez Faba, O., et al.
Publicado: (2012)

Towards a New Concept of Regenerative Endodontics Based on Mesenchymal Stem Cell-Derived Secretomes Products
por: Costa, Luis A., et al.
Publicado: (2022)

Altered Maternal Serum Matrix Metalloproteinases MMP-2, MMP-3, MMP-9, and MMP-13 in Severe Early- and Late-Onset Preeclampsia
por: Laskowska, Marzena
Publicado: (2017)

26,26,26,27,27,27-Hexadeuterated-1,25-Dihydroxyvitamin D(3) (1,25D-d(6)) As Adjuvant of Chemotherapy in Breast Cancer Cell Lines
por: Seoane, Samuel, et al.
Publicado: (2013)

Assessment of the concentration of selected metalloproteinases (MMP-2, MMP-3, MMP-9 and MMP-13) in patients with ulcers as a complication of type 2 diabetes
por: Kupczyk, Daria, et al.
Publicado: (2020)

Mesenchymal Stem Cell-Based Therapy as an Alternative to the Treatment of Acute Respiratory Distress Syndrome: Current Evidence and Future Perspectives
por: Fernández-Francos, Silvia, et al.
Publicado: (2021)

Tumor-Derived Matrix Metalloproteinase-13 (MMP-13) Expression in Benign and Malignant Breast Lesions
por: Ameli, Fereshteh, et al.
Publicado: (2021)

The Coronavirus Pandemic (SARS-CoV-2): New Problems Demand New Solutions, the Alternative of Mesenchymal (Stem) Stromal Cells
por: Eiro, Noemi, et al.
Publicado: (2020)

Aging and Mesenchymal Stem Cells: Basic Concepts, Challenges and Strategies
por: Fraile, Maria, et al.
Publicado: (2022)

Tumor-derived Matrix Metalloproteinase-13 (MMP-13) correlates with poor prognoses of invasive breast cancer
por: Zhang, Bin, et al.
Publicado: (2008)

The Significance of Matrix Metalloproteinase 9 (MMP-9) and Metalloproteinase 2 (MMP-2) in Urinary Bladder Cancer
por: Kudelski, Jacek, et al.
Publicado: (2023)

Development of a Non-Hydroxamate Dual Matrix Metalloproteinase (MMP)-7/-13 Inhibitor
por: Fischer, Thomas, et al.
Publicado: (2017)

Mesenchymal (Stem) Stromal Cells Based as New Therapeutic Alternative in Inflammatory Bowel Disease: Basic Mechanisms, Experimental and Clinical Evidence, and Challenges
por: Eiro, Noemi, et al.
Publicado: (2022)

Regulation of the prometastatic neuregulin–MMP13 axis by SRC family kinases: therapeutic implications
por: Orive‐Ramos, Ana, et al.
Publicado: (2017)

Antifungal Activity of the Human Uterine Cervical Stem Cells Conditioned Medium (hUCESC-CM) Against Candida albicans and Other Medically Relevant Species of Candida
por: Schneider, José, et al.
Publicado: (2018)

Corrigendum: Antifungal Activity of the Human Uterine Cervical Stem Cells Conditioned Medium (hUCESC-CM) Against Candida albicans and Other Medically Relevant Species of Candida
por: Schneider, José, et al.
Publicado: (2019)

Expression of metalloproteinases (MMP-2 and MMP-9) in basal-cell carcinoma
por: Goździalska, Anna, et al.
Publicado: (2016)

Breast Cancer Tumor Stroma: Cellular Components, Phenotypic Heterogeneity, Intercellular Communication, Prognostic Implications and Therapeutic Opportunities
por: Eiro, Noemi, et al.
Publicado: (2019)

Mesenchymal Stem Cells in Homeostasis and Systemic Diseases: Hypothesis, Evidences, and Therapeutic Opportunities
por: Vizoso, Francisco J., et al.
Publicado: (2019)

Matrix Metalloproteinase 13 (MMP13) Is a Direct Target of Osteoblast-Specific Transcription Factor Osterix (Osx) in Osteoblasts
por: Zhang, Chi, et al.
Publicado: (2012)

High threshold of β1 integrin inhibition required to block collagen I-induced membrane type-1 matrix metalloproteinase (MT1-MMP) activation of matrix metalloproteinase 2 (MMP-2)
por: Borrirukwanit, Kulrut, et al.
Publicado: (2014)

Analysis of the Gene Expression Profile of Stromal Pro-Tumor Factors in Cancer-Associated Fibroblasts from Luminal Breast Carcinomas
por: Eiro, Noemi, et al.
Publicado: (2020)

Importance of the origin of mesenchymal (stem) stromal cells in cancer biology: “alliance” or “war” in intercellular signals
por: Eiro, Noemi, et al.
Publicado: (2021)

Expression and function of matrix metalloproteinase (MMP)-28
por: Rodgers, Ursula R., et al.
Publicado: (2009)

Role of Matrix Metalloproteinase (MMP) 2 and MMP-9 in Soft Tissue Sarcoma
por: Yang, Hyun Kee, et al.
Publicado: (2014)

Correlation between expression of matrix metalloproteinase-2 (MMP-2), and matrix metalloproteinase-9 (MMP-9) and angiogenesis in colorectal adenocarcinoma.
por: Kim, T. S., et al.
Publicado: (1999)

Pulley Blocks v. Inspection Pits
Publicado: (1909)

Cannot write session to /tmp/vufind_sessions/sess_f5i6kuqklh0q9e9g7pfunj9sms